FINWIRES · TerminalLIVE
FINWIRES

Cytokinetics Insider Sold Shares Worth $606,525, According to a Recent SEC Filing

By

Robert I Blum, Director, President & CEO, on July 27, 2026, sold 7,500 shares in Cytokinetics (CYTK) for $606,525. Following the Form 4 filing with the SEC, Blum has control over a total of 381,986 common shares of the company, with 377,820 shares held directly and 4,166 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000106198326000085/xslF345X05/form4.xml

Related Articles